INTRA-CELLULAR THERAPIES, Inc.
57 patents in portfolio
US12264160utility2025
Pharmaceutical Compositions Comprising 4-((6br, 10as)-3-methyl-2,3,6b,9,10,10a-hexahydro-1h,7h-pyrido[3′,4′:4,5]pyrrolo[1,2,3-de]quinoxalin-8-yl)-1-(4-fluorophenyl)butan-1-one for Treating Central Nervous System DisordersUS12240850utility2025
Pharmaceutical Compositions Comprising 4-((6br, 10as)-3-methyl-2,3,6b,9,10, 10a-hexahydro-1h,7h-pyrido[3′,4′:4,5]pyrrolo[1,2,3-de]quinoxalin-8-yl)-1-(4-fluorophenyl)butan-1-ol for Treating Central Nervous System DisordersUS12194042utility2025
UsesUS12139490utility2024
Process for Preparing 1-(4-fluorophenyl)-4-((6br, 10as)-3-methyl-2,3,6b,9,10,10a-hexahydro-1h-pyrido[3′,4′:4,5]pyrrolo[1,2,3-de]quinoxalin-8(7h)-yl)butan-1-oneUS12122792utility2024
Pharmaceutical Compositions Comprising 4-((6br,10as)-3-methyl2,3,6b,9,10,10a-hexahydro-1h-pyrido[3′,4′:4,5]pyrrolo[1,2,3-de]quinoxalin8(7h)-yl)-1-(4-((6br,10as)-3-methyl-2,3,6b,9,10,10a-hexahydro-1h-pyrido[3′,4′:4,5]pyrrolo[1,2,3-de]quinoxalin-8(7h)-yl)phenyl)butan-1-one for Treating Conditions of the Central Nervous System and Cardiac Disorders